These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10066347)

  • 1. A divalent major histocompatibility complex/IgG1 fusion protein induces antigen-specific T cell activation in vitro and in vivo.
    Cullen CM; Jameson SC; DeLay M; Cottrell C; Becken ET; Choi E; Hirsch R
    Cell Immunol; 1999 Feb; 192(1):54-62. PubMed ID: 10066347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
    Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
    Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo.
    Carey B; DeLay M; Strasser JE; Chalk C; Dudley-McClain K; Milligan GN; Brunner HI; Thornton S; Hirsch R
    Clin Immunol; 2005 Jul; 116(1):65-76. PubMed ID: 15925833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.
    Chen X; Yan Y; Lu S; Weng X; Liang Z; Li J; Zhong M; Tang J; Xiao W; Sun W; Shen G; Wu X
    Hum Immunol; 2009 Feb; 70(2):79-84. PubMed ID: 19100802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
    Jhaver KG; Chandler P; Simpson E; Mellor AL
    J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
    Liu X; Zhang L; Zhang X; Yu H; Zhao X; Lu J; Qian G; Ge S
    Int J Oncol; 2007 Jun; 30(6):1389-96. PubMed ID: 17487359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses.
    Lebowitz MS; O'Herrin SM; Hamad AR; Fahmy T; Marguet D; Barnes NC; Pardoll D; Bieler JG; Schneck JP
    Cell Immunol; 1999 Mar; 192(2):175-84. PubMed ID: 10087186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice.
    Majeau GR; Meier W; Jimmo B; Kioussis D; Hochman PS
    J Immunol; 1994 Mar; 152(6):2753-67. PubMed ID: 7511625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
    Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
    Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
    Liu A; Hu P; Khawli LA; Epstein AL
    Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera.
    Casares S; Stan AC; Bona CA; Brumeanu TD
    Nat Biotechnol; 2001 Feb; 19(2):142-7. PubMed ID: 11175728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
    Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
    J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
    Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
    Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.